Shoa L Clarke1, Themistocles L Assimes2,3. 1. Department of Medicine, Division of Cardiovascular Medicine, Stanford University, Stanford, CA, USA. 2. Department of Medicine, Division of Cardiovascular Medicine, Stanford University, Stanford, CA, USA. tassimes@stanford.edu. 3. VA Palo Alto Health Care System, Palo Alto, CA, USA. tassimes@stanford.edu.
Abstract
PURPOSE OF REVIEW: Genome-wide association studies (GWAS) have been the primary tool for unbiased assessment of the genetic basis of coronary artery disease (CAD) for more than a decade. We summarize successes as well as shortcomings of recent studies in this context. RECENT FINDINGS: The number of CAD-associated loci has more than doubled in the past year to 161. This rapid progress has been in large part due to the release of genome-wide genotyping data for the largely European participants of the UK Biobank study which has been combined with existing GWAS from the CARDIoGRAMplusC4D consortium. Additional discoveries have been achieved through large-scale genotyping of participants using custom high-yield genotyping arrays including the Metabochip and the Exome chip. As a consequence, the ability of genetic risk scores in predicting incident CAD events has improved but that improvement has only been shown in European populations. GWAS have proven to be a fruitful approach for uncovering the genetic drivers of CAD. However, determining the mechanisms of association of GWAS findings remains a challenging endeavor requiring long-term investment. Genetic risk scores offer an opportunity for recent findings to have an immediate clinical impact. Going forward, CAD genetics will benefit greatly from the release of more genetic data produced by mega-biobanks. These new data will allow for the more comprehensive examination of underrepresented populations.
PURPOSE OF REVIEW: Genome-wide association studies (GWAS) have been the primary tool for unbiased assessment of the genetic basis of coronary artery disease (CAD) for more than a decade. We summarize successes as well as shortcomings of recent studies in this context. RECENT FINDINGS: The number of CAD-associated loci has more than doubled in the past year to 161. This rapid progress has been in large part due to the release of genome-wide genotyping data for the largely European participants of the UK Biobank study which has been combined with existing GWAS from the CARDIoGRAMplusC4D consortium. Additional discoveries have been achieved through large-scale genotyping of participants using custom high-yield genotyping arrays including the Metabochip and the Exome chip. As a consequence, the ability of genetic risk scores in predicting incident CAD events has improved but that improvement has only been shown in European populations. GWAS have proven to be a fruitful approach for uncovering the genetic drivers of CAD. However, determining the mechanisms of association of GWAS findings remains a challenging endeavor requiring long-term investment. Genetic risk scores offer an opportunity for recent findings to have an immediate clinical impact. Going forward, CAD genetics will benefit greatly from the release of more genetic data produced by mega-biobanks. These new data will allow for the more comprehensive examination of underrepresented populations.
Authors: Amir Tajbakhsh; Mohammad Sadegh Khorrami; Seyed Mahdi Hassanian; Malihe Aghasizade; Alireza Pasdar; Mina Maftouh; Ehsan Tabatabai; Seyed Mohammad Reza Parizadeh; Mostafa Fazeli; Gordon A Ferns; Majid Ghayour-Mobarhan; Amir Avan Journal: Curr Pharm Des Date: 2016 Impact factor: 3.116
Authors: Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov Journal: Proc Natl Acad Sci U S A Date: 2005-09-30 Impact factor: 11.205
Authors: Guillaume Lettre; Cameron D Palmer; Taylor Young; Kenechi G Ejebe; Hooman Allayee; Emelia J Benjamin; Franklyn Bennett; Donald W Bowden; Aravinda Chakravarti; Al Dreisbach; Deborah N Farlow; Aaron R Folsom; Myriam Fornage; Terrence Forrester; Ervin Fox; Christopher A Haiman; Jaana Hartiala; Tamara B Harris; Stanley L Hazen; Susan R Heckbert; Brian E Henderson; Joel N Hirschhorn; Brendan J Keating; Stephen B Kritchevsky; Emma Larkin; Mingyao Li; Megan E Rudock; Colin A McKenzie; James B Meigs; Yang A Meng; Tom H Mosley; Anne B Newman; Christopher H Newton-Cheh; Dina N Paltoo; George J Papanicolaou; Nick Patterson; Wendy S Post; Bruce M Psaty; Atif N Qasim; Liming Qu; Daniel J Rader; Susan Redline; Muredach P Reilly; Alexander P Reiner; Stephen S Rich; Jerome I Rotter; Yongmei Liu; Peter Shrader; David S Siscovick; W H Wilson Tang; Herman A Taylor; Russell P Tracy; Ramachandran S Vasan; Kevin M Waters; Rainford Wilks; James G Wilson; Richard R Fabsitz; Stacey B Gabriel; Sekar Kathiresan; Eric Boerwinkle Journal: PLoS Genet Date: 2011-02-10 Impact factor: 5.917
Authors: Cathie Sudlow; John Gallacher; Naomi Allen; Valerie Beral; Paul Burton; John Danesh; Paul Downey; Paul Elliott; Jane Green; Martin Landray; Bette Liu; Paul Matthews; Giok Ong; Jill Pell; Alan Silman; Alan Young; Tim Sprosen; Tim Peakman; Rory Collins Journal: PLoS Med Date: 2015-03-31 Impact factor: 11.069
Authors: Nora Franceschini; Yijuan Hu; Alex P Reiner; Steven Buyske; Mike Nalls; Lisa R Yanek; Yun Li; Lucia A Hindorff; Shelley A Cole; Barbara V Howard; Jeanette M Stafford; Cara L Carty; Praveen Sethupathy; Lisa W Martin; Dan-Yu Lin; Karen C Johnson; Lewis C Becker; Kari E North; Abbas Dehghan; Joshua C Bis; Yongmei Liu; Philip Greenland; JoAnn E Manson; Nobuyo Maeda; Melissa Garcia; Tamara B Harris; Diane M Becker; Christopher O'Donnell; Gerardo Heiss; Charles Kooperberg; Eric Boerwinkle Journal: PLoS One Date: 2014-12-26 Impact factor: 3.240
Authors: Adam Auton; Lisa D Brooks; Richard M Durbin; Erik P Garrison; Hyun Min Kang; Jan O Korbel; Jonathan L Marchini; Shane McCarthy; Gil A McVean; Gonçalo R Abecasis Journal: Nature Date: 2015-10-01 Impact factor: 49.962
Authors: Benjamin F Voight; Hyun Min Kang; Jun Ding; Cameron D Palmer; Carlo Sidore; Peter S Chines; Noël P Burtt; Christian Fuchsberger; Yanming Li; Jeanette Erdmann; Timothy M Frayling; Iris M Heid; Anne U Jackson; Toby Johnson; Tuomas O Kilpeläinen; Cecilia M Lindgren; Andrew P Morris; Inga Prokopenko; Joshua C Randall; Richa Saxena; Nicole Soranzo; Elizabeth K Speliotes; Tanya M Teslovich; Eleanor Wheeler; Jared Maguire; Melissa Parkin; Simon Potter; N William Rayner; Neil Robertson; Kathleen Stirrups; Wendy Winckler; Serena Sanna; Antonella Mulas; Ramaiah Nagaraja; Francesco Cucca; Inês Barroso; Panos Deloukas; Ruth J F Loos; Sekar Kathiresan; Patricia B Munroe; Christopher Newton-Cheh; Arne Pfeufer; Nilesh J Samani; Heribert Schunkert; Joel N Hirschhorn; David Altshuler; Mark I McCarthy; Gonçalo R Abecasis; Michael Boehnke Journal: PLoS Genet Date: 2012-08-02 Impact factor: 5.917
Authors: Bohdan B Khomtchouk; Diem-Trang Tran; Kasra A Vand; Matthew Might; Or Gozani; Themistocles L Assimes Journal: Brief Bioinform Date: 2020-12-01 Impact factor: 11.622
Authors: Teresa Infante; Luca Del Viscovo; Maria Luisa De Rimini; Sergio Padula; Pio Caso; Claudio Napoli Journal: J Atheroscler Thromb Date: 2019-11-12 Impact factor: 4.928
Authors: Alexandra S Shadrina; Tatiana I Shashkova; Anna A Torgasheva; Sodbo Z Sharapov; Lucija Klarić; Eugene D Pakhomov; Dmitry G Alexeev; James F Wilson; Yakov A Tsepilov; Peter K Joshi; Yurii S Aulchenko Journal: Sci Rep Date: 2020-06-26 Impact factor: 4.379
Authors: Kristin Torgersen; Shahram Bahrami; Oleksandr Frei; Alexey Shadrin; Kevin S O' Connell; Olav B Smeland; John Munkhaugen; Srdjan Djurovic; Toril Dammen; Ole A Andreassen Journal: Transl Psychiatry Date: 2021-06-17 Impact factor: 6.222